citalopram
These highlights do not include all the information needed to use CITALOPRAM CAPSULES safely and effectively. See full prescribing information for CITALOPRAM CAPSULES. CITALOPRAM capsules, for oral use Initial U.S. Approval: 1998
2f815b0c-6da7-cb61-e89c-7de628092d0d
HUMAN PRESCRIPTION DRUG LABEL
Aug 24, 2023
Almatica Pharma LLC
DUNS: 962454505
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
citalopram
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Drug Labeling Information
BOXED WARNING SECTION
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
INDICATIONS & USAGE SECTION
1 INDICATIONS AND USAGE
Citalopram Capsules are indicated for the treatment of Major Depressive Disorder (MDD) in adults [see Clinical Studies (14)].
Citalopram Capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for treatment of Major Depressive Disorder (MDD) in adults. (1)
RECENT MAJOR CHANGES SECTION
RECENT MAJOR CHANGES
|
Warnings and Precautions (5.3, 5.4) |
8/2023 |